Preliminary development of a new individualised questionnaire measuring quality of life in older men with age-related hormonal decline: The A-RHDQoL

被引:12
作者
Carolyn V McMillan
Clare Bradley
Manthos Giannoulis
Finbarr Martin
Peter H Sönksen
机构
[1] Department of Psychology, University of London, Egham, Surrey, Royal Holloway
[2] GKT School of Medicine, London, St. Thomas' Campus
关键词
A-RHDQoL; Age-related hormonal decline; Quality of life;
D O I
10.1186/1477-7525-1-51
中图分类号
学科分类号
摘要
Background: There is increasing interest in hormone replacement therapy to improve health and quality of life (QoL) of older men with age-related decline in hormone levels. This paper reports the preliminary development and evaluation of the psychometric properties of a new individualised questionnaire, the A-RHDQoL, measuring perceived impact of age-related hormonal decline on QoL of older men. A-RHDQoL design was based on the HDQoL for people with growth hormone (GH) deficiency and the ADDQoL (for diabetes). Methods: Internal consistency reliability and some aspects of validity of the A-RHDQoL were investigated in a cross- sectional survey of 128 older men (age range: 64 - 80 yrs), being screened for inclusion in a trial of GH and testosterone (T) replacement, and who completed the A-RHDQoL once. Respondents rated personally applicable life domains for importance and impact of their hormonal decline. A single overview item measured present QoL. Serum levels of Insulinlike Growth Factor-I and total T were measured. Results: Of the 24 A-RHDQoL domains, 21 were rated as relevant and important for older men. All domains were perceived as negatively impacted by hormonal decline. The most negatively impacted domains were: memory (-4.54 ± 3.02), energy (-4.44 ± 2.49), sex life (-4.34 ± 3.08) and physical stamina (-4.29 ± 2.41), (maximum range -9 to +9). The shorter 21-domain A-RHDQoL had high internal consistency reliability (Cronbach's alpha coefficient = 0.935, N = 103) and applicable domains could be weighted and summed into an overall Average Weighted Impact score. The questionnaire was acceptable to the majority of respondents and content validity was good. The single overview item measuring present QoL correlated significantly with total T levels [r = 0.26, p <0.01, N = 114]. Conclusion: The new 21-item A-RHDQoL is an individualised questionnaire measuring perceived impact of age-related hormonal decline on the QoL of older men. The internal consistency reliability and content validity of the A-RHDQoL are established, but the measure is at an early stage of its development and its sensitivity to change and other psychometric properties need now to be evaluated in clinical trials of hormone replacement in older men. © 2003 McMillan et al; licensee BioMed Central Ltd.
引用
收藏
页数:12
相关论文
共 43 条
[1]  
The World Population Prospects: The 2000 Revision, (2003)
[2]  
Hermann M., Berger P., Hormone replacement in the aging male?, Exp. Gerontol., 34, pp. 923-933, (1999)
[3]  
Rudman D., Kutner M.H., Rogers C.M., Lubin M.F., Fleming G.A., Bain R.P., Impaired growth-hormone secretion in the adult population - Relation to age and adiposity, J. Clin. Invest., 67, pp. 1361-1369, (1981)
[4]  
Vermeulen A., Clinical review 24: Androgens in the aging male, J. Clin. Endocrinol. Metab., 73, pp. 221-224, (1991)
[5]  
Carroll P.V., Christ E.R., Growth hormone deficiency in adulthood and the effects of growth hormone replacement: A review, J. Clin. Endocrinol. Metab., 83, pp. 382-395, (1998)
[6]  
Colao A., di Somma C., Cuocolo A., Spinelli L., Tedesco N., Pivonello R., Bonaduce D., Salvatore M., Lombardi G., Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (gh) replacement in young adult patients with gh deficiency, J. Clin. Endocrinol. Metab., 86, pp. 1874-1881, (2001)
[7]  
Howell S., Shalet S., Testosterone deficiency and replacement, Horm. Res., 56, SUPPL. 1, pp. 86-92, (2001)
[8]  
Snyder P.J., Peachey H., Berlin J.A., Hannoush P., Haddad G., Dlewati A., Santanna J., Loh L., Lenrow D.A., Holmes J.H., Kapoor S.C., Atkinson L.E., Strom B.L., Effects of testosterone replacement in hypogonadal men, J. Clin. Endocrinol. Metab., 85, pp. 2670-2677, (2000)
[9]  
Martin F.C., Frailty and the somatopause, Growth Horm. IGF Res., 9, pp. 3-10, (1999)
[10]  
Anawalt B.D., Merriam G.R., Neuroendocrine aging in men. Andropause and somatopause, Endocrinol. Metab. Clin. North Am., 30, pp. 647-669, (2001)